プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Beema T.に依頼

India

4 years of experience in Scientific writing & HEOR | Expert in Meta-analysis, NMA & Pharmacovigilance | R Studio & SPSS

プロフィール概要

PhD Scholar

専門分野

• ☆ Biostatistics
• ☆ Data Collection
• ☆ SPSS
• ☆ R
• ☆ Pharmacy
• ☆ Pharmacy Education
• ☆ Clinical Pharmacy
• ☆ Public Health
• ☆ Epidemiology
• ☆ Health Technology Assessment
• ☆ Counseling & Mental Health Support
• ☆ Schizophrenia
• ☆ Psychiatry
• ☆ Psychopharmacology
• ☆ Cognitive Behavioral Therapy
• ☆ Health Risk Assessments
• ☆ Geriatric Psychiatry

サービス

• Writing

Writing Medical Writing, Technical Writing, Copywriting, Creative Writing, General Proofreading & Editing

職務経験

PhD Research Scholar

National Institute of Pharmaceutical Education and Research

7月 2021 - 現在

Drug Safety Associate Trainee

IQVIA (India)

3月 2021 - 10月 2021

学歴

PhD (Department of Pharmacy Practice)

National Institute of Pharmaceutical Education and Research

8月 2021 - 現在

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Beema T Yoosuf, Rachana Mehta, Sanjit Sah (2025). Concerns and implications of Oropouche virus infection during pregnancy: A call for further research and public health action . New Microbes and New Infections.

Beema T Yoosuf, KT Muhammed Favas, Mamidi Niveditha, Manideep Bhukya, Parul Chawla Gupta, Pinaki Dutta, Dipika Bansal (2025). Insights into the systemic risk factors associated with diabetic retinopathy in the Indian population: A comprehensive systematic review and meta-analysis . Indian Journal of Ophthalmology.

Beema T Yoosuf, Muhammed Favas Karimbanathottathil, M Mamatha, Dipika Bansal (2024). Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials . Scientific Reports.

Beema T. Yoosuf, Manisa Pattanayak, Sanjit Sah (2024). Vorasidenib: A Milestone in Targeted Therapy for IDH-Mutant Lower Grade Gliomas - Efficacy, Emerging Safety Concerns, and the Call for Comprehensive Safety Evaluation . Current Drug Safety.

Beema T Yoosuf, Abhilash Kumar Panda, Muhammed Favas KT, Saroj Kundan Bharti, Sudheer Kumar Devana, Dipika Bansal (2024). Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis . Scientific Reports.

Beema T Yoosuf, Muhammed Favas KT, Pinaki Dutta, Dipika Bansal (2024). Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms . Expert Opinion on Drug Safety.

Kt MF, Semwal M, Yoosuf BT, Lad D, Bansal D. Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS. Ann Hematol. 2024 Feb 26. doi: 10.1007/s00277-024-05676-1. Epub ahead of print. PMID: 38403712 .

CONFERENCE PAPER

Beema T Yoosuf, Muhammed Favas Kt (2024). [1288] | Gastrointestinal Adverse Events withGlucagon-like Peptide-1 Receptor Agonist in Type2 Diabetes: A Comprehensive Meta-analysis ofRandomised Controlled Trials and Refining Signalsthrough Pharmacovigilance Analysis . 2024 ISPE Annual Meeting.

Beema T Yoosuf, Muhammed Favas KT (2024). [441] Isatuximab Adverse Event Monitoring: A Safety Meta-Analysis of Randomized Controlled Trials and Refining Signals through Pharmacovigilance Analysis . 2024 ISPE Annual Meeting.

BOOK CHAPTER

Beema T Yoosuf, Dipika Bansal, Muhammed KT Favas Role of Medical Coding in Signal Detection. Signal Analysis in Pharmacovigilance.

Beema T Yoosuf, Dipika Bansal, Muhammed KT Favas Bayesian Methods of Signal Detection. Signal Analysis in Pharmacovigilance.